BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 04-May-2016

The Company has informed that The Board of Directors has decided, according to the Companies Act, 1994 and The Directives dated 27th April, 2016 of BSEC, to extend the Financial Year (FY) 2015-2016 of the Company by an additional period of 3 months comprising to 15 months period ending on 30th June, 2016 instead of 31st March, 2016 in order to comply with the uniform income year from July to June as per provision of Section 9 of the Finance Act, 2015.

SQURPHARMA 31-Jan-2016

(Q3 Un-audited): Consolidated EPS was Tk. 3.39 for October-December, 2015 as against Tk. 2.45 for October-December, 2014; Consolidated EPS was Tk. 9.48 for April-December, 2015 as against Tk. 6.77 for April-December, 2014. Consolidated NOCFPS was Tk. 12.59 for April-December, 2015 as against Tk. 7.75 for April-December, 2014. Consolidated NAV per share was Tk. 56.86 as of December 31, 2015 and Tk. 49.86 as of March 31, 2015.

SQURPHARMA 25-Jan-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2016 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on December 31, 2015.

SQURPHARMA 28-Oct-2015

(Q2 Un-audited): Consolidated EPS was Tk. 3.18 for July-September, 2015 as against Tk. 2.09 for July-September, 2014; Consolidated EPS was Tk. 6.09 for April-September, 2015 as against Tk. 4.32 for April-September, 2014. Consolidated NOCFPS was Tk. 6.87 for April-September, 2015 as against Tk. 3.94 for April-September, 2014. Consolidated NAV per share was Tk. 53.37 as of September 30, 2015 and Tk. 49.86 as of March 31, 2015.

SQURPHARMA 21-Oct-2015

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2015 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on September 30, 2015.

SQURPHARMA 06-Oct-2015

The Company has informed that it has credited the bonus shares for the year ended on March 31, 2015 to the respective shareholders' BO Accounts.

SQURPHARMA 08-Sep-2015

Credit Rating Information and Services Limited (CRISL) has rated the Company as "AAA" in the long term and "ST-1" in the short term along with a stable outlook in consideration of its audited financials up to March 31, 2015, unaudited financials up to June 30, 2015 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

SQURPHARMA 16-Aug-2015

(Q1 Un-audited): Consolidated EPS for April-June, 2015 was Tk. 3.28 as against Tk. 2.51 for April-June, 2014; Consolidated NOCFPS was Tk. 3.11 for April-June, 2015 as against Tk. 1.76 for April-June, 2014. Consolidated NAV per share was Tk. 59.38 as of June 30, 2015 and Tk. 56.09 as of March 31, 2015.

SQURPHARMA 13-Aug-2015

Normal trading of the shares of the Company will resume on 16.08.2015 after record date.

SQURPHARMA 12-Aug-2015

Trading of the shares of the Company will remain suspended on record date i.e., 13.08.2015.

Previous Next page